 |
PDBsum entry 2foj
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Hydrolase
|
 |
|
Title:
|
 |
The crystal structure of the n-terminal domain of hausp/usp7 complexed with p53 peptide 364-367
|
|
Structure:
|
 |
Ubiquitin carboxyl-terminal hydrolase 7. Chain: a. Fragment: math domain. Synonym: ubiquitin thiolesterase 7, ubiquitin-specific processing protease 7, deubiquitinating enzyme 7, herpesvirus associated ubiquitin-specific protease. Engineered: yes. P53 peptide. Chain: b.
|
|
Source:
|
 |
Homo sapiens. Human. Organism_taxid: 9606. Gene: usp7, hausp. Expressed in: escherichia coli bl21(de3). Expression_system_taxid: 469008. Synthetic: yes
|
|
Biol. unit:
|
 |
Dimer (from
)
|
|
Resolution:
|
 |
|
1.60Å
|
R-factor:
|
0.229
|
R-free:
|
0.262
|
|
|
Authors:
|
 |
V.Saridakis,Y.Sheng,F.Sarkari,S.Duan,T.Wu,C.H.Arrowsmith,L.Frappier
|
Key ref:
|
 |
Y.Sheng
et al.
(2006).
Molecular recognition of p53 and MDM2 by USP7/HAUSP.
Nat Struct Mol Biol,
13,
285-291.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
13-Jan-06
|
Release date:
|
14-Feb-06
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
Q93009
(UBP7_HUMAN) -
Ubiquitin carboxyl-terminal hydrolase 7 from Homo sapiens
|
|
|
|
Seq: Struc:
|
 |
 |
 |
1102 a.a.
137 a.a.
|
|
|
|
|
|
|
|
|
 |
 |
|
|
Key: |
 |
PfamA domain |
 |
 |
 |
Secondary structure |
 |
 |
CATH domain |
 |
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
E.C.3.4.19.12
- ubiquitinyl hydrolase 1.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
Thiol-dependent hydrolysis of ester, thiolester, amide, peptide and isopeptide bonds formed by the C-terminal Gly of ubiquitin (a 76-residue protein attached to proteins as an intracellular targeting signal).
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Nat Struct Mol Biol
13:285-291
(2006)
|
|
PubMed id:
|
|
|
|
|
| |
|
Molecular recognition of p53 and MDM2 by USP7/HAUSP.
|
|
Y.Sheng,
V.Saridakis,
F.Sarkari,
S.Duan,
T.Wu,
C.H.Arrowsmith,
L.Frappier.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The ubiquitin-specific protease, USP7, has key roles in the p53 pathway whereby
it stabilizes both p53 and MDM2. We show that the N-terminal domain of USP7
binds two closely spaced 4-residue sites in both p53 and MDM2, falling between
p53 residues 359-367 and MDM2 residues 147-159. Cocrystal structures with USP7
were determined for both p53 peptides and for one MDM2 peptide. These peptides
bind the same surface of USP7 as Epstein-Barr nuclear antigen-1, explaining the
competitive nature of the interactions. The structures and mutagenesis data
indicate a preference for a P/AXXS motif in peptides that bind USP7. Contacts
made by serine are identical and crucial for all peptides, and Trp165 in the
peptide-binding pocket of USP7 is also crucial. These results help to elucidate
the mechanism of substrate recognition by USP7 and the regulation of the p53
pathway.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
|
 |
Figure 1.
Figure 1. Crystal structure of USP7 NTD bound to p53 site
359-PGGS-362. (a) Transparent surface diagrams of p53–USP7.
(b) Detailed interactions between USP7 (light gray) and p53
(dark gray). (c) Overlay of p53 (red) and EBNA1 (green) peptides
from complex structures. (d) Overlay of p53 (red) and TRANCE-R
(yellow) peptides from complex structures, showing conserved
interactions with USP7 (purple) and TRAF6 (blue) residues.
|
 |
Figure 2.
Figure 2. Crystal structure of USP7 NTD bound to p53 site
364-AHSS-367. (a) Transparent surface diagram of USP7 NTD
bound by p53 mutant peptide 358-EAGGARAHSS-367 (blue). (b)
Detailed interactions between USP7 (light gray) and p53 (dark
gray). (c) Overlay of p53 peptides 359-PGGS-362 (red) and
364-AHSS-367 (turquoise) from USP7 complex structures.
|
 |
Figure 4.
Figure 4. Crystal structure of USP7 NTD bound to MDM2 peptide 4.
(a) Transparent surface diagram of MDM2-USP7. (b) Detailed
interactions between USP7 (light gray) and MDM2 (dark gray). (c)
Overlay of MDM2 (blue) and p53 359-PGGS-362 (red) peptides from
USP7 complex structures.
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from Macmillan Publishers Ltd:
Nat Struct Mol Biol
(2006,
13,
285-291)
copyright 2006.
|
|
| |
Figures were
selected
by the author.
|
|
|
| |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
|
| |
The three figures above relate to the three structures 2foo, 2foj and
2fop as follows:
Figure 1:
USP7-p53 359-362 interaction.
Figure 2:
USP7-p53 364-367 interaction.
Figure 4:
USP7-mdm2 interaction.
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
H.R.Lee,
W.C.Choi,
S.Lee,
J.Hwang,
E.Hwang,
K.Guchhait,
J.Haas,
Z.Toth,
Y.H.Jeon,
T.K.Oh,
M.H.Kim,
and
J.U.Jung
(2011).
Bilateral inhibition of HAUSP deubiquitinase by a viral interferon regulatory factor protein.
|
| |
Nat Struct Mol Biol,
18,
1336-1344.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
L.Frappier,
and
C.P.Verrijzer
(2011).
Gene expression control by protein deubiquitinases.
|
| |
Curr Opin Genet Dev,
21,
207-213.
|
 |
|
|
|
|
 |
N.E.Davey,
G.Travé,
and
T.J.Gibson
(2011).
How viruses hijack cell regulation.
|
| |
Trends Biochem Sci,
36,
159-169.
|
 |
|
|
|
|
 |
Z.Huang,
Q.Wu,
O.A.Guryanova,
L.Cheng,
W.Shou,
J.N.Rich,
and
S.Bao
(2011).
Deubiquitylase HAUSP stabilizes REST and promotes maintenance of neural progenitor cells.
|
| |
Nat Cell Biol,
13,
142-152.
|
 |
|
|
|
|
 |
F.Sarkari,
Y.Sheng,
and
L.Frappier
(2010).
USP7/HAUSP promotes the sequence-specific DNA binding activity of p53.
|
| |
PLoS One,
5,
e13040.
|
 |
|
|
|
|
 |
J.Yuan,
K.Luo,
L.Zhang,
J.C.Cheville,
and
Z.Lou
(2010).
USP10 regulates p53 localization and stability by deubiquitinating p53.
|
| |
Cell,
140,
384-396.
|
 |
|
|
|
|
 |
F.E.Reyes-Turcu,
K.H.Ventii,
and
K.D.Wilkinson
(2009).
Regulation and cellular roles of ubiquitin-specific deubiquitinating enzymes.
|
| |
Annu Rev Biochem,
78,
363-397.
|
 |
|
|
|
|
 |
J.F.Burrows,
A.A.Kelvin,
C.McFarlane,
R.E.Burden,
M.J.McGrattan,
M.De la Vega,
U.Govender,
D.J.Quinn,
K.Dib,
M.Gadina,
C.J.Scott,
and
J.A.Johnston
(2009).
USP17 regulates Ras activation and cell proliferation by blocking RCE1 activity.
|
| |
J Biol Chem,
284,
9587-9595.
|
 |
|
|
|
|
 |
S.Daubeuf,
D.Singh,
Y.Tan,
H.Liu,
H.J.Federoff,
W.J.Bowers,
and
K.Tolba
(2009).
HSV ICP0 recruits USP7 to modulate TLR-mediated innate response.
|
| |
Blood,
113,
3264-3275.
|
 |
|
|
|
|
 |
A.C.Joerger,
and
A.R.Fersht
(2008).
Structural biology of the tumor suppressor p53.
|
| |
Annu Rev Biochem,
77,
557-582.
|
 |
|
|
|
|
 |
G.Chen,
H.Huang,
O.Fröhlich,
Y.Yang,
J.D.Klein,
S.R.Price,
and
J.M.Sands
(2008).
MDM2 E3 ubiquitin ligase mediates UT-A1 urea transporter ubiquitination and degradation.
|
| |
Am J Physiol Renal Physiol,
295,
F1528-F1534.
|
 |
|
|
|
|
 |
J.A.Nathan,
S.Sengupta,
S.A.Wood,
A.Admon,
G.Markson,
C.Sanderson,
and
P.J.Lehner
(2008).
The ubiquitin E3 ligase MARCH7 is differentially regulated by the deubiquitylating enzymes USP7 and USP9X.
|
| |
Traffic,
9,
1130-1145.
|
 |
|
|
|
|
 |
L.Song,
and
M.Rape
(2008).
Reverse the curse--the role of deubiquitination in cell cycle control.
|
| |
Curr Opin Cell Biol,
20,
156-163.
|
 |
|
|
|
|
 |
N.Sivachandran,
F.Sarkari,
and
L.Frappier
(2008).
Epstein-Barr nuclear antigen 1 contributes to nasopharyngeal carcinoma through disruption of PML nuclear bodies.
|
| |
PLoS Pathog,
4,
e1000170.
|
 |
|
|
|
|
 |
S.Singhal,
M.C.Taylor,
and
R.T.Baker
(2008).
Deubiquitylating enzymes and disease.
|
| |
BMC Biochem,
9,
S3.
|
 |
|
|
|
|
 |
Y.Ruano,
M.Mollejo,
F.I.Camacho,
A.Rodríguez de Lope,
C.Fiaño,
T.Ribalta,
P.Martínez,
J.L.Hernández-Moneo,
and
B.Meléndez
(2008).
Identification of survival-related genes of the phosphatidylinositol 3'-kinase signaling pathway in glioblastoma multiforme.
|
| |
Cancer,
112,
1575-1584.
|
 |
|
|
|
|
 |
A.Fernández-Montalván,
T.Bouwmeester,
G.Joberty,
R.Mader,
M.Mahnke,
B.Pierrat,
J.M.Schlaeppi,
S.Worpenberg,
and
B.Gerhartz
(2007).
Biochemical characterization of USP7 reveals post-translational modification sites and structural requirements for substrate processing and subcellular localization.
|
| |
FEBS J,
274,
4256-4270.
|
 |
|
|
|
|
 |
C.L.Brooks,
M.Li,
M.Hu,
Y.Shi,
and
W.Gu
(2007).
The p53--Mdm2--HAUSP complex is involved in p53 stabilization by HAUSP.
|
| |
Oncogene,
26,
7262-7266.
|
 |
|
|
|
|
 |
F.Toledo,
and
G.M.Wahl
(2007).
MDM2 and MDM4: p53 regulators as targets in anticancer therapy.
|
| |
Int J Biochem Cell Biol,
39,
1476-1482.
|
 |
|
|
|
|
 |
K.Li,
B.Ossareh-Nazari,
X.Liu,
C.Dargemont,
and
R.Marmorstein
(2007).
Molecular basis for bre5 cofactor recognition by the ubp3 deubiquitylating enzyme.
|
| |
J Mol Biol,
372,
194-204.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
L.F.Stevenson,
A.Sparks,
N.Allende-Vega,
D.P.Xirodimas,
D.P.Lane,
and
M.K.Saville
(2007).
The deubiquitinating enzyme USP2a regulates the p53 pathway by targeting Mdm2.
|
| |
EMBO J,
26,
976-986.
|
 |
|
|
|
|
 |
V.H.Wood,
J.D.O'Neil,
W.Wei,
S.E.Stewart,
C.W.Dawson,
and
L.S.Young
(2007).
Epstein-Barr virus-encoded EBNA1 regulates cellular gene transcription and modulates the STAT1 and TGFbeta signaling pathways.
|
| |
Oncogene,
26,
4135-4147.
|
 |
|
|
|
|
 |
M.Renatus,
S.G.Parrado,
A.D'Arcy,
U.Eidhoff,
B.Gerhartz,
U.Hassiepen,
B.Pierrat,
R.Riedl,
D.Vinzenz,
S.Worpenberg,
and
M.Kroemer
(2006).
Structural basis of ubiquitin recognition by the deubiquitinating protease USP2.
|
| |
Structure,
14,
1293-1302.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
T.Sulea,
H.A.Lindner,
and
R.Ménard
(2006).
Structural aspects of recently discovered viral deubiquitinating activities.
|
| |
Biol Chem,
387,
853-862.
|
 |
|
|
|
|
 |
Y.Pereg,
S.Lam,
A.Teunisse,
S.Biton,
E.Meulmeester,
L.Mittelman,
G.Buscemi,
K.Okamoto,
Y.Taya,
Y.Shiloh,
and
A.G.Jochemsen
(2006).
Differential roles of ATM- and Chk2-mediated phosphorylations of Hdmx in response to DNA damage.
|
| |
Mol Cell Biol,
26,
6819-6831.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
');
}
}
 |